The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Capsule switching of Neisseria meningitidis
Open accessAbstract
The different sialic acid (serogroups B, C, Y, and W-135) and nonsialic acid (serogroup A) capsular polysaccharides expressed by Neisseria meningitidis are major virulence factors and are used as epidemiologic markers and vaccine targets. However, the identification of meningococcal isolates with similar genetic markers but expressing different capsular polysaccharides suggests that meningococcal clones can switch the type of capsule they express. We identified, except for capsule, isogenic serogroups B [(α2→8)-linked polysialic acid] and C [(α2→9)-linked polysialic acid] meningococcal isolates from an outbreak of meningococcal disease in the U. S. Pacific Northwest. We used these isolates and prototype serogroup A, B, C, Y, and W-135 strains to define the capsular biosynthetic and transport operons of the major meningococcal serogroups and to show that switching from the B to C capsule in the outbreak strain was the result of allelic exchange of the polysialyltransferase. Capsule switching was probably the result of transformation and horizontal DNA exchange in vivo of a serogroup C capsule biosynthetic operon. These findings indicate that closely related virulent meningococcal clones may not be recognized by traditional serogroup-based surveillance and can escape vaccine-induced or natural protective immunity by capsule switching. Capsule switching may be an important virulence mechanism of meningococci and other encapsulated bacterial pathogens. As vaccine development progresses and broader immunization with capsular polysaccharide conjugate vaccines becomes a reality, the ability to switch capsular types may have important implications for the impact of these vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
Sierra, G. V. G., Campa, H. C., Varcacel, N. M., Garcia, I. L., Izquierdo, P., Sotolongo, P. F., Casanueva, G. V., Rico, C. O., Rodriguez, C. R., & Terry, M. H. (1991) · PubMed · Cited by 512
Principles and practice of infectious diseases
Brook, M. G. (1990) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(90)90352-f · Cited by 389
Coffey, T. J., Dowson, C. G., Daniels, M., Zhou, J., Martin, C., Spratt, B. G., & Musser, J. M. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb02155.x · Cited by 314
Serogroup C meningococcal outbreaks in the United States. An emerging threat
Jackson, L. A. (1995) · JAMA · doi:10.1001/jama.273.5.383 · Cited by 256
Caugant, D. A., Mocca, L. F., Frasch, C. E., Frøholm, L. O., Zollinger, W. D., & Selander, R. K. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.6.2781-2792.1987 · Cited by 251
Hammerschmidt, S., Hilse, R., van Putten, J. P. M., Gerardy‐Schahn, R., Schubert‐Unkmeir, A., & Frosch, M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00347.x · Cited by 211
Whalen, C. M. (1995) · JAMA · doi:10.1001/jama.273.5.390 · Cited by 195
Frosch, M., Weisgerber, C., & Meyer, T. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.5.1669 · Cited by 194
Cited by
Maiden, M. C. J., Bygraves, J. A., Feil, E., Morelli, G., Russell, J. E., Urwin, R., Zhang, Q., Zhou, J., Zurth, K., Caugant, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3140 · Cited by 3,833
Rosenstein, N. E., Perkins, B. A., Stephens, D. S., Popovic, T., & Hughes, J. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441807 · Cited by 1,169
Self-citationEpidemic meningitis, meningococcaemia, and Neisseria meningitidis
Stephens, D. S., Greenwood, B., & Brandtzaeg, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61016-2 · Cited by 978
Self-citationGlobal epidemiology of meningococcal disease
Harrison, L. H., Trotter, C. L., & Ramsay, M. E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.063 · Cited by 755
Active Bacterial Core Surveillance of the Emerging Infections Program Network
Schuchat, A., Hilger, T., Zell, E., Farley, M. M., Reingold, A., Harrison, L., Lefkowitz, L., Danila, R., Stefonek, K., Barrett, N., et al. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0701.010114 · Cited by 592
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
van Deuren, M., Brandtzaeg, P., & van der Meer, J. W. M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.144 · Cited by 588
Tettelin, H., Masignani, V., Cieslewicz, M. J., Eisen, J. A., Peterson, S., Wessels, M. R., Paulsen, I. T., Nelson, K. E., Margarit, I., Read, T. D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182380799 · Cited by 500
Neisseria meningitidis: Biology, Microbiology, and Epidemiology
Rouphael, N. G., & Stephens, D. S. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-346-2_1 · Cited by 425
Self-citationNeisseria meningitidis: an overview of the carriage state
Yazdankhah, S. P., & Caugant, D. A. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45529-0 · Cited by 379
Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
Pichichero, M. E. (2013) · Human vaccines & immunotherapeutics · doi:10.4161/hv.26109 · Cited by 261
Population genetics and molecular epidemiology of Neisseria meningitidis
CAUGANT, D. A. (1998) · APMIS · doi:10.1111/j.1699-0463.1998.tb01379.x · Cited by 255
Meningococcal C conjugate vaccine: the experience in England and Wales
Campbell, H., Borrow, R., Salisbury, D., & Miller, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.067 · Cited by 168
Ladhani, S. N., Flood, J. S., Ramsay, M. E., Campbell, H., Gray, S. J., Kaczmarski, E. B., Mallard, R. H., Guiver, M., Newbold, L. S., & Borrow, R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.03.011 · Cited by 124
Rendueles, O., Garcia-Garcerà, M., Néron, B., Touchon, M., & Rocha, E. P. C. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006525 · Cited by 89
Ram, S., Shaughnessy, J., DeOliveira, R. B., Lewis, L. A., Gulati, S., & Rice, P. A. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.05.016 · Cited by 35
Metadata
- Authors
- Swartley, J. S., Marfin, A. A., Edupuganti, S., Liu, L.-J., Cieslak, P., Perkins, B., Wenger, J. D., & Stephens, D. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-01-07
- Volume
- 94
- Issue
- 1
- Pages
- 271-276
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2154892242
- Cited by
- 383
- References
- 23
- FWCI
- 10.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.